Literature DB >> 20638714

Is HAART modifying the HIV epidemic?

Franco Maggiolo1, Sebastiano Leone.   

Abstract

Mesh:

Year:  2010        PMID: 20638714     DOI: 10.1016/S0140-6736(10)61057-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health.

Authors:  Susan Kippax; Niamh Stephenson
Journal:  Am J Public Health       Date:  2012-05       Impact factor: 9.308

2.  Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.

Authors:  S Leone; M Prosperi; S Costarelli; P Nasta; F Maggiolo; S Di Giambenedetto; A Saracino; M Di Pietro; A Gori
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-06       Impact factor: 3.267

3.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

4.  Combination therapy: the next opportunity and challenge of medicine.

Authors:  Paolo A Ascierto; Francesco M Marincola
Journal:  J Transl Med       Date:  2011-07-21       Impact factor: 5.531

5.  Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance.

Authors:  Chinh Tran-To Su; Wei-Li Ling; Wai-Heng Lua; Yu-Xuan Haw; Samuel Ken-En Gan
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

6.  Restricted access to antiretroviral treatment for undocumented migrants: a bottle neck to control the HIV epidemic in the EU/EEA.

Authors:  Jessika Deblonde; André Sasse; Julia Del Amo; Fiona Burns; Valerie Delpech; Susan Cowan; Michele Levoy; Lilana Keith; Anastasia Pharris; Andrew Amato-Gauci; Teymur Noori
Journal:  BMC Public Health       Date:  2015-12-10       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.